Table 1. Comparison of clinical variables between the T2DM and control groups.
| Variables | Control (n = 272) | T2DM (n = 445) | P-value | P’-value |
|---|---|---|---|---|
| Age (years) | 54.19 ± 13.50 | 56.06 ± 12.10 | 0.063 | 1 |
| Gender | ||||
| Male, n (%) | 141 (51.84) | 262 (58.88) | – | |
| Female, n (%) | 131 (48.16) | 183 (41.12) | 0.065 | 1 |
| BMI | 23.92 ± 3.29 | 24.83 ± 3.52 | 0.001** | 0.018* |
| Hyperlipidemia, n (%) | 80 (29.41) | 248 (55.73) | <0.001*** | 0.018* |
| TP (g/L) | 75.44 ± 4.49 | 68.25 ± 7.16 | <0.001*** | 0.018* |
| ALB (g/L) | 45.63 ± 2.64 | 40.39 ± 5.61 | <0.001*** | 0.018* |
| GLB (g/L) | 29.80 ± 3.85 | 27.84 ± 4.83 | <0.001*** | 0.018* |
| ALB/GLB | 1.50 ± 0.30 | 1.50 ± 0.40 | 0.022* | 0.396 |
| BUN (mmol/L) | 5.29 ± 1.32 | 5.81 ± 2.54 | <0.001*** | 0.018* |
| Scr (μmol/L) | 70.00 ± 26.00 | 69.00 ± 26.00 | 0.124 | 1 |
| SUA (μmol/L) | 348.33 ± 95.43 | 341.28 ± 97.79 | 0.349 | 1 |
| FBG (mmol/L) | 4.79 ± 0.64 | 8.73 ± 4.85 | <0.001*** | 0.018* |
| TC (mmol/L) | 5.14 ± 0.93 | 4.99 ± 1.19 | 0.068 | 1 |
| TG (mmol/L) | 1.50 ± 1.12 | 1.71 ± 1.22 | <0.001*** | 0.018* |
| HDL-C (mmol/L) | 1.49 ± 0.37 | 1.11 ± 0.37 | <0.001*** | 0.018* |
| LDL-C (mmol/L) | 2.83 ± 0.78 | 2.85 ± 0.97 | 0.764 | 1 |
| APOA1 (g/L) | 1.29 ± 0.19 | 1.13 ± 0.28 | <0.001*** | 0.018* |
| APOB (g/L) | 0.88 ± 0.20 | 0.89 ± 0.25 | 0.396 | 1 |
Notes.
- TP
- total protein
- ALB
- albumin
- GLB
- globulin
- ALB/GLB
- albumin/globulin
- BUN
- blood urea nitrogen
- Scr
- serum creatinine
- SUA
- serum uric acid
- FBG
- fasting blood glucose
- TC
- total cholesterol
- TG
- triglyceride
- HDL-C
- high density lipoprotein cholesterol
- LDL-C
- low density lipoprotein cholesterol
- APOA1
- apolipoprotein A1
- APOB
- apolipoprotein B
- P’-value
- adjusted for age and gender
*
P < 0.05
**
P < 0.01
***
P < 0.001